FRE — Fresenius SE & Co KGaA Balance Sheet
0.000.00%
- €24.61bn
- €21.26bn
- €22.87bn
Annual balance sheet for Fresenius SE & Co KGaA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 931 | 574 | 75 | 336 | — |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 9,308 | 9,124 | 6,027 | 5,513 | — |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 17,461 | 18,279 | 12,520 | 11,446 | — |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 18,583 | 18,841 | 10,782 | 9,890 | — |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 71,962 | 76,400 | 45,284 | 43,550 | — |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 15,062 | 13,658 | 9,330 | 9,009 | — |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 52,964 | 55,985 | 26,285 | 24,008 | — |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 18,998 | 20,415 | 18,999 | 19,542 | — |
| Total Liabilities & Shareholders' Equity | 71,962 | 76,400 | 45,284 | 43,550 | — |
| Total Common Shares Outstanding |